EPO Still In Turmoil As Supervisory Body Backs Dismissal Of High-Level Staff 20/10/2015 by Intellectual Property Watch Leave a Comment The European Patent Organisation has been in turmoil for years facing serious staff dissent and complaints aimed at EPO President Benoît Battistelli of France. The EPO’s effort appears to have intensified in recent months, and on Friday the EPO Administrative Council, the agency’s supervisory body, announced an action to back Battistelli and endorsed a request for the dismissal of a high-level staff member. The action sent critics to new levels of criticism.
At WIPO, Panel Urges Women To Get Out Of Their Comfort Zones 20/10/2015 by Marianna Drake for Intellectual Property Watch 1 Comment Panellists at a recent discussion on women and intellectual property proposed steps institutions and women themselves could take to increase the number of female entrepreneurs, in order for the IP system to benefit men and women equally.
“The Brain Is The Next Frontier,” Bioethics Futurist Says, Raising New Societal Challenges 19/10/2015 by Marianna Drake for Intellectual Property Watch 6 Comments At the recent TEDx CERN event, Intellectual Property Watch caught up with bioethicist and legal philosopher Matthew Liao, to reflect on challenging moral questions raised by new advances in computing and neuroscience allowing for the manipulation of human thoughts and memories. Liao reflected on whether we should use drugs and technology to erase traumatic memories, and if individuals have a moral obligation to themselves to remember certain events.
WTO TRIPS Council Addresses Non-Violation, Paragraph 6 Drug Exports 15/10/2015 by William New and Catherine Saez, Intellectual Property Watch 3 Comments The World Trade Organization intellectual property committee today addressed exports of cheaper medicines, and disputes that could arise even when there is no WTO violation. Tomorrow it will decide the hot-button issue of how long least-developed countries have before they must comply with international IP trade rules – on which LDCs said today they are ready to talk about a deal.
Health Groups Urge EU Commission To Safeguard Access To Medicines In Developing Countries 14/10/2015 by Intellectual Property Watch Leave a Comment Health Action International (HAI) and Médecins Sans Frontières (MSF – Doctors without Borders) today issued a joint report on European Union commitments to safeguard access to medicines. Their report [pdf] comes in the context of the revision of the European Union’s trade and investment policy, released today.
European Council Backs LDC Extension At WTO 13/10/2015 by Intellectual Property Watch Leave a Comment The European Council has confirmed that it will support the request of least developed countries at the World Trade Organization for the extension of a waiver of intellectual property obligations for pharmaceutical products.
A New Model For IP: Interview With Ecuador IP Office Director Hernán Núñez Rocha 13/10/2015 by Intellectual Property Watch 2 Comments Ecuador is preparing a new intellectual property policy that aims to better suit the country’s strategic development. On the occasion of the World Intellectual Property Organization General Assembly, Hernán Núñez Rocha, head of the Ecuadorian IP office sat with Intellectual Property Watch to talk about the country’s work on the IP policy and its use of IP as a tool for local development. He also explained Ecuador’s position on the WIPO committee on traditional knowledge.
Chatham House Report On Antibiotics Gives Evidence For Drug R&D Delinkage 09/10/2015 by Catherine Saez, Intellectual Property Watch 1 Comment A new report from Chatham House presenting suggestions for novel business models for antibiotics calls for models in which the return on investment in research and development is not dependent on the volume of sales, also known as delinkage.
“No Human Right To Patent Protection,” Says UN Rapporteur On Cultural Rights 08/10/2015 by Catherine Saez, Intellectual Property Watch 3 Comments In a new report, the United Nations Special Rapporteur in the field of cultural rights examines the implications of patent policy for the right to science and culture. She gives a number of recommendations calling for countries to refrain from granting stringent patent protection, and respect their human right obligations.
At WTO, Governments, Health Advocates See Benefit From TRIPS; LDC Waiver Urged 07/10/2015 by Catherine Saez, Intellectual Property Watch 2 Comments Access to medicines and innovations was the subject of a panel organised at the World Trade Organization Public Forum last week. After 20 years of the WTO intellectual property agreement, panellists looked at the impact of the agreement on access to medicines, and in particular the use of its flexibilities. In addition, a delegate of India detailed the legal-political aspects of an upcoming WTO decision on disputes for harmful actions that do not technically violate any WTO rules.